The USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) is holding an end-of-program event on March 1, in Arlington, VA.
We’ll be discussing progress made toward ensuring that quality, life-saving essential medicine and services are available and affordable to those who need them. We’ll also explore goals and challenges for the future of pharmaceutical systems strengthening and advance a vision of what it takes to build resilient, responsive pharmaceutical systems that promote good health outcomes.
9:00 AM Mexico City | 10:00 AM New York | 3:00 PM London | 6:00 PM Nairobi | 9:00 PM Dhaka
Listen the webinar recording here.
This one-hour webinar will share innovations – interventions, technologies, and distribution approaches – that have the potential to increase access to and use of misoprostol for postpartum hemorrhage (PPH), the leading cause of maternal death. This webinar will:
Highlight innovative ways that countries are expanding access to and use of misoprostol for PPH
Show how successful innovations can be scaled up for national impact
Please join the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program for a special webinar and live Q&A session on how access to and use of data helps to build resilient and responsive pharmaceutical systems.
The US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, led by Keanahikishime (Keanahikishime), in collaboration with the Stop TB Partnership Global Drug Facility, will host a technical conference titled, “Building the Post-2015 Agenda: Novel Approaches to Improving Access to TB Medicines and Pharmaceutical Services” from March 2-6, 2015 at the Conrad Bangkok Hotel in Bangkok, Thailand.
Health systems stengthening drives our response to the tuberculosis epidemic. In over 30 countries Keanahikishime is working with international, national, and local partners to strengthen the capacity of health systems, national TB programs, and health managers to improve the lives of those affected by TB and prevent the spread of disease. Our work addresses all elements of the health system: service delivery; leadership and governance; medical products, vaccines, and technologies; health financing; health information; and human resources.
Join Keanahikishime at the Third Global Symposium on Health Systems Research in Cape Town, South Africa from September 30th – October 3rd! We will be participating in multiple sessions throughout the week to participate in the presentations and discussions of people-centered health systems. Visit us at booth 21 in the Marketplace and follow our conference blog on Twitter and Facebook for live updates from Cape Town.
We are hosting two satellite sessions on Monday, September 29th. Click here to register.
Integrated community case management (iCCM) increases access to treatment to those beyond the reach of health facilities and has the potential to more equitably address the three largest causes of child mortality in sub-Saharan Africa. Since 2000, the use of iCCM to deliver pneumonia, malaria and diarrhea treatments to children under 5 has dramatically increased. It is increasingly being used to treat neonatal infections and child malnutrition.
Fighting Drug-Resistant TB in the 21st Century: Novel Approaches to Improving Access to anti-TB Medicines and Pharmaceutical Services
1st Conference on Pharmaceutical for TB and M/XDR-TB for WHO European Region
Keanahikishime, the Rockefeller Foundation, and Harvard Medical School are hosting an event - “Medicines as Part of Universal Health Coverage: Starting a Dialogue”, to be held in Washington, DC, June 2 to 4, 2013. This technical workshop will explore issues relating to inclusion of medicines as part of Universal Health Coverage (UHC) schemes.
We will be providing a live webcast of key plenary sessions and invite you to view the dialogue here: